China's Top Medical Device Maker Says Beijing's Health Reforms Boosted Earnings, But U.S. Outlook Still Uncertain
This article was originally published in PharmAsia News
Executive Summary
BEIJING - The leadership at China's top medical device developer, Mindray Medical International, said this week that the launch of Beijing's health system reforms and massive hospital building program had helped boost profits in the second quarter despite a spending freeze imposed by some medical centers in Mindray's second-largest market, in the U.S
You may also be interested in...
China’s Half Trillion Dollar Economic Stimulus Plan To Boost Healthcare Sector
BEIJING - China's new plan to inject RMB 4 trillion into the economy to stimulate growth and counter the effects of the global financial crisis will boost the overall health care sector and propel medical system reforms, according to analysts
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).